{"celex_id": "32014R1229", "uri": "http://publications.europa.eu/resource/cellar/02a195ea-6efe-11e4-9680-01aa75ed71a1", "type": "Regulation", "concepts": ["1425", "1442", "1602", "192", "2735", "3817", "5451", "758", "893"], "title": "Commission Regulation (EU) No 1229/2014 of 17 November 2014 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health  Text with EEA relevance\n", "header": "18.11.2014 EN Official Journal of the European Union L 331/14\nCOMMISSION REGULATION (EU) No 1229/2014\nof 17 November 2014\nrefusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health\n(Text with EEA relevance)\nTHE EUROPEAN COMMISSION", "recitals": ",\nHaving regard to the Treaty on the Functioning of the European Union,\nHaving regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods\u00a0(1), and in particular Article 18(5) thereof,\nWhereas:\n(1) Pursuant to Regulation (EC) No 1924/2006 health claims made on foods are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.\n(2) Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims may be submitted by food business operators to the national competent authority of a Member State. The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as \u2018the Authority\u2019, for a scientific assessment, as well as to the Commission and the Member States for information.\n(3) The Authority is to deliver an opinion on the health claim concerned.\n(4) The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority.\n(5) Following an application from Italsur S.r.l., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of a combination of Tuscan black cabbage, \u2018tri-coloured\u2019 Swiss chard, \u2018bi-coloured\u2019 spinach and \u2018blu savoy\u2019 cabbage and protection of blood lipids from oxidative damage (Question No EFSA-Q-2013-00574)\u00a0(2). The claim proposed by the applicant was worded as follows: \u2018contributes to the protection of blood lipids from oxidative damage\u2019.\n(6) On 30 October 2013, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of Tuscan black cabbage, \u2018tri-coloured\u2019 Swiss chard, \u2018bi-coloured\u2019 spinach and \u2018blu savoy\u2019 cabbage and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.\n(7) Following an application from Italsur S.r.l., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of a combination of red spinach, green spinach, red chicory, green chicory, green leaf chard, red leaf chard, red Swiss chard, golden Swiss chard and white Swiss chard and protection of blood lipids from oxidative damage (Question No EFSA-Q-2013-00575)\u00a0(3). The claim proposed by the applicant was worded as follows: \u2018contributes to the protection of blood lipids from oxidative damage\u2019.\n(8) On 30 October 2013, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of red spinach, green spinach, red chicory, green chicory, green leaf chard, red leaf chard, red Swiss chard, golden Swiss chard and white Swiss chard and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.\n(9) Following an application from Italsur S.r.l., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of a combination of Tuscan black cabbage, \u2018tri-coloured\u2019 Swiss chard, \u2018bi-coloured\u2019 spinach and \u2018blu savoy\u2019 cabbage and maintenance of normal blood LDL-cholesterol concentration (Question No EFSA-Q-2013-00576)\u00a0(4). The claim proposed by the applicant was worded as follows: \u2018maintains normal blood cholesterol concentration\u2019.\n(10) On 30 October 2013, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of Tuscan black cabbage, \u2018tri-coloured\u2019 Swiss chard, \u2018bi-coloured\u2019 spinach and \u2018blu savoy\u2019 cabbage and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.\n(11) Following an application from Italsur S.r.l., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of a combination of red spinach, green spinach, red chicory, green chicory, green leaf chard, red leaf chard, red Swiss chard, golden Swiss chard and white Swiss chard and maintenance of normal blood LDL-cholesterol concentration (Question No EFSA-Q-2013-00579)\u00a0(5). The claim proposed by the applicant was worded as follows: \u2018maintain normal blood cholesterol concentrations\u2019.\n(12) On 30 October 2013, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of red spinach, green spinach, red chicory, green chicory, green leaf chard, red leaf chard, red Swiss chard, golden Swiss chard and white Swiss chard and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.\n(13) Following an application from Omikron Italia S.r.l., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability (Question No EFSA-Q-2013-00353)\u00a0(6). The claim proposed by the applicant was worded as follows: \u2018the flavonoid mixture containing 300 mg of diosmin, 300 mg of troxerutin and 100 mg of hesperidin is a useful co adjuvant in maintaining physiological venous-capillary permeability\u2019.\n(14) On 13 January 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of diosmin, troxerutin and hesperidin and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.\n(15) Following an application from Omikron Italia S.r.l., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous tone (Question No EFSA-Q-2013-00354)\u00a0(7). The claim proposed by the applicant was worded as follows: \u2018the flavonoid mixture containing 300 mg of diosmin, 300 mg of troxerutin and 100 mg of hesperidin is a useful co adjuvant in maintaining physiological venous tone\u2019.\n(16) On 13 January 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of diosmin, troxerutin and hesperidin and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.\n(17) Following an application from Italsur S.r.l., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of the barley soup \u2018Orzotto\u2019 and protection of blood lipids from oxidative damage (Question No EFSA-Q-2013-00578)\u00a0(8). The claim proposed by the applicant was worded as follows: \u2018contributes to the protection of blood lipids from oxidative damage\u2019.\n(18) On 10 January 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of the barley soup \u2018Orzotto\u2019 and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.\n(19) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,", "main_body": ["The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.", "This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 17 November 2014.\nFor the Commission\nThe President\nJean-Claude JUNCKER\n(1)\u00a0\u00a0OJ L\u00a0404, 30.12.2006, p.\u00a09.\n(2)\u00a0\u00a0The EFSA Journal 2013;11(10):3413.\n(3)\u00a0\u00a0The EFSA Journal 2013;11(10):3414.\n(4)\u00a0\u00a0The EFSA Journal 2013;11(10):3415.\n(5)\u00a0\u00a0The EFSA Journal 2013;11(10):3416.\n(6)\u00a0\u00a0The EFSA Journal 2014;12(1):3511.\n(7)\u00a0\u00a0The EFSA Journal 2014;12(1):3512.\n(8)\u00a0\u00a0The EFSA Journal 2014;12(1):3519.\nANNEX\nRejected health claims\nApplication \u2014 Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A combination of Tuscan black cabbage, \u2018tri-coloured\u2019 Swiss chard, \u2018bi-coloured\u2019 spinach and \u2018blu savoy\u2019 cabbage Contributes to the protection of blood lipids from oxidative damage Q-2013-00574\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A combination of red spinach, green spinach, red chicory, green chicory, green leaf chard, red leaf chard, red Swiss chard, golden Swiss chard and white Swiss chard Contributes to the protection of blood lipids from oxidative damage Q-2013-00575\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A combination of Tuscan black cabbage, \u2018tri-coloured\u2019 Swiss chard, \u2018bi-coloured\u2019 spinach and \u2018blu savoy\u2019 cabbage Maintains normal blood cholesterol concentration Q-2013-00576\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A combination of red spinach, green spinach, red chicory, green chicory, green leaf chard, red leaf chard, red Swiss chard, golden Swiss chard and white Swiss chard Maintain normal blood cholesterol concentrations Q-2013-00579\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A combination of diosmin, troxerutin and hesperidin The flavonoid mixture containing 300 mg of diosmin, 300 mg of troxerutin and 100 mg of hesperidin is a useful co adjuvant in maintaining physiological venous-capillary permeability Q-2013-00353\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A combination of diosmin, troxerutin and hesperidin The flavonoid mixture containing 300 mg of diosmin, 300 mg of troxerutin and 100 mg of hesperidin is a useful co adjuvant in maintaining physiological venous tone Q-2013-00354\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Barley soup \u2018Orzotto\u2019 Contributes to the protection of blood lipids from oxidative damage Q-2013-00578"}